These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9499670)

  • 1. Resistance to activated protein C as a risk factor of stroke in a thalassemic patient.
    Giordano P; Sabato V; Schettini F; De Mattia D; Iolascon A
    Haematologica; 1997; 82(6):698-700. PubMed ID: 9499670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent transient ischemic attacks in a 15-year-old boy with beta-thalassemia minor and thrombophilia. Contribution of perfusion SPECT to clinical diagnosis.
    Engelborghs S; Pickut BA; De Deyn PP
    Acta Neurol Belg; 2003 Jun; 103(2):99-102. PubMed ID: 12892004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activated protein C resistance as a cause of thrombophilia].
    Ruiz-Argüelles GJ
    Rev Invest Clin; 1996; 48(3):223-9. PubMed ID: 8966383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of functional testing for resistance to activated protein C and molecular biological testing for factor V R506Q in 370 patients.
    Montes MA; Fox EA; Longtine JA; Dorfman DM
    Arch Pathol Lab Med; 1998 Apr; 122(4):325-9. PubMed ID: 9648899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital resistance to activated protein C in patients with lupus anticoagulants: evaluation of two functional assays.
    Galli M; Duca F; Ruggeri L; Finazzi G; Negri B; Moia M
    Thromb Haemost; 1998 Aug; 80(2):246-9. PubMed ID: 9716147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
    Montaruli B; Schinco P; Pannocchia A; Giorgianni A; Borchiellini A; Tamponi G; Pileri A
    Thromb Haemost; 1997 Sep; 78(3):1042-8. PubMed ID: 9308751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
    Favaloro EJ; Mirochnik O; McDonald D
    Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [National evaluation of the diagnosis of activated protein C resistance].
    Montiel-Manzano G; de la Peña-Díaz A; Majluf-Cruz A; Cesarman-Maus G; Corona-de la Peña N; Cruz-Cruz D; Gaminio E; Martínez-Murillo C; Mayagoitia T; Miranda-Peralta E; Poblete T; Quintana-Martínez S; Ramírez R; Razo D; Ruiz de Chávez-Ochoa A; Reyes-Núñez VA; Salazar R; Vicencio-Santiago GV; Villa R
    Rev Invest Clin; 2003; 55(3):358-69. PubMed ID: 14515684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method.
    De Bel AV; Van der Cruyssen GA; Devreese KM
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):155-60. PubMed ID: 16479199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in hemostasis system in patients with hereditary thrombophilia caused by mutation of blood coagulation factor V ( factor V Leiden)].
    Papaian LP; Kobilianskaia VA; Sheĭdina AM; Baranovskaia SS; Sirotkina OV; Kargin VD; Saltykova NB; Beliazo OE; Golovina OG; Papaian KA; Tarkovskaia LR
    Ter Arkh; 2001; 73(7):47-51. PubMed ID: 11523408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain.
    Olave T; Cornudella R; Homs C; Azaceta G; Tirado I; Gutierrez M
    Haematologica; 1998 Apr; 83(4):378-80. PubMed ID: 9592991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for resistance to activated protein C factor V R506Q.
    Mack R; Albanese E; Fernandes H
    Arch Pathol Lab Med; 1998 Dec; 122(12):1046. PubMed ID: 9870848
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.
    Ragland BD; Reed CE; Eiland BM; Tichenor PH; Hudson CL; Fritsma GA; Adler BK; Marques MB
    Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Brain stem ischemia in a boy with resistance to C activated protein and elevated lipoprotein A].
    Sameiro-Barreirinho M; Costa E; Moreira A; Barbot J; Barbot C; Santos M
    Rev Neurol; 1999 Jun 1-15; 28(11):1061-4. PubMed ID: 10390775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited activated protein C resistance in a patient with familial primary antiphospholipid syndrome.
    Alarcón-Segovia D; Ruiz-Argüelles GJ; Garcés-Eisele J; Ruiz-Argüelles A
    J Rheumatol; 1996 Dec; 23(12):2162-5. PubMed ID: 8970058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C resistance and factor V Leiden in Mexico.
    Majluf-Cruz A; Moreno-Hernández M; Ruiz-de-Chávez-Ochoa A; Monroy-García R; Majluf-Cruz K; Guardado-Mendoza R; Molina-Avila I; Isordia-Salas I; Corona-de la Peña N; Vargas-Vorackova F; Vela-Ojeda J; García-Chávez J
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):428-37. PubMed ID: 18160617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.